Ureaplasma urealyticum in Pregnancy: Significance, Symptoms, and Management

Ureaplasma urealyticum and U. parvum are common genital mycoplasmas. Key points for pregnancy:

Prevalence and Significance

  • Colonize 40–80% of sexually active women asymptomatically.
  • Not routinely screened for in pregnancy. No consensus that treatment improves outcomes.
  • Associated with (but not proven causal for): preterm labor, chorioamnionitis, low birth weight, neonatal respiratory distress.
  • Vertical transmission occurs (50% of infants born to colonized mothers), usually transient colonization.

Symptomatic Infection

If Ureaplasma causes urethritis/cervicitis:

  • Dysuria, urinary frequency, urethral discharge.
  • Mucopurulent cervical discharge, friability.
  • Diagnosis: NAAT (PCR) from urine/cervical swab. Culture less sensitive.

Treatment in Pregnancy

  • Azithromycin 1 g PO single dose — preferred (safe, effective, covers co-pathogens).
  • Erythromycin base 500 mg QID × 7 days — alternative.
  • Doxycycline CONTRAINDICATED in pregnancy (teratogenic).
  • Treat partner simultaneously to prevent reinfection.

Asymptomatic Colonization

Routine treatment not recommended by CDC/ACOG. Insufficient evidence for preterm birth prevention. Individualize if high-risk history (prior PTB, short cervix) — discuss with MFM specialist.

Neonatal Considerations

  • Can cause neonatal pneumonia, meningitis (rare).
  • If neonate symptomatic: azithromycin IV/PO.

Bottom line: Ureaplasma is often a commensal. Treat only if symptomatic or in specific high-risk contexts per specialist guidance.

Urinary Disorders - Related Articles